EAN 2017: Cannabinoids suitable for migraine prophylaxis

Written by Lauren Pulling, Editor

A study presented at the Congress of the European Academy of Neurology (Amsterdam, The Netherlands, 24–27 June 2017) has confirmed that cannabinoids are suitable for migraine prophylaxis. The study – led by Maria Nicolodi (Interuniversity Center, Florence, Italy) – investigated the use of cannabinoids for migraine prevention as well as the treatment of migraine and acute cluster headaches. Interestingly, findings indicated that cannabinoids are only effective at treating acute cluster headaches in patients who have suffered from migraine in childhood. Researchers first investigated the effective dosage of cannabinoids for treating headaches. After administrating varying oral doses containing concentrations of 19%...

To view this content, please register now for access

It's completely free